- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.08. | Motus GI Holdings, Inc. - 15-12G, Securities registration termination | 4 | SEC Filings | ||
| 31.07. | Motus GI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.06. | Motus GI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.06. | Motus GI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.2024 | 2.470 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV.... ► Artikel lesen | |
| 18.03. | Motus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | 218 | GlobeNewswire (Europe) | Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process... ► Artikel lesen | |
| 21.02. | Motus GI Holdings, Inc.: Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu System to Avoid Clogging in Cleansing the GI Tract | 225 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. ("the "Company") (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences... ► Artikel lesen | |
| 30.01. | Motus GI Holdings, Inc.: Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation | 183 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or "Motus GI" or "the Company"), a medical technology company focused on improving endoscopic outcomes... ► Artikel lesen | |
| MOTUS GI Aktie jetzt für 0€ handeln | |||||
| 19.12.23 | Pre-market Movers: Infobird, Jin Medical International, Motus GI, Panbela Therapeutics, Shengfeng Development | 1.030 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.10 A.M. ET).In the Green Infobird Co., Ltd (IFBD) is up over 80% at $2.44.
Jin... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 83,00 | -0,16 % | Medtronic plc (NYSE:MDT) Shares Purchased by Meridian Investment Counsel Inc. | ||
| INTUITIVE SURGICAL | 500,80 | -0,12 % | Opening Bell: Wall Street startet behauptet; Rally bei Shopify, Grab, Intuitive Surgical, ... | Nach der vom Wahlsieg Donald Trumps beflügelten jüngsten Gewinnserie der US-Aktienmärkte dürfte es am Dienstag zunächst ruhig zugehen. Eine Dreiviertelstunde vor Handelsbeginn taxierte der Broker IG... ► Artikel lesen | |
| ROKU | 65,65 | +0,44 % | Alphabet, Crowdstrike und Roku mit Fokus auf Allzeithochs | News von Trading-Treff.de Die Aktien von Alphabet, Crowdstrike und Roku zeigen aktuell sehr bullische Chartbilder. Korrekturen nach momentumgetriebenen Rallies bieten aktuell immer wieder gute Chancen... ► Artikel lesen | |
| SERNOVA | 0,158 | -0,69 % | Sernova Aktie: Fortschritte bei Cell Pouch System | Die kanadische Biotechnologiefirma Sernova verzeichnet bedeutende Entwicklungen bei ihrer innovativen Cell Pouch Technologie. Das Unternehmen, das sich auf regenerative Medizinlösungen für chronische... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,202 | -1,48 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Announced positive topline results from KARISMA-Endoxifen Phase 2 study which demonstrated that low doses of (Z)-endoxifen significantly reduced mammographic breast density (MBD), addressing a key... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel | BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| QUIDELORTHO | 34,400 | 0,00 % | Activist investor Jana cuts Frontier bet, liquidates QuidelOrtho, BlackLine | ||
| TEMPEST THERAPEUTICS | 0,842 | -0,18 % | Tempest Therapeutics: Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update | Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agreement... ► Artikel lesen | |
| ONTRAK | 1,883 | 0,00 % | Ontrak Health Announces 2024 Third Quarter Financial Results | MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results... ► Artikel lesen | |
| VERU | 0,560 | -0,44 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen | |
| CENTENE | 54,36 | -0,40 % | Chutes & Ladders-Centene president to retire, Abridge and AccessHope tap industry execs | ||
| PATTERSON COMPANIES | 18,700 | 0,00 % | Patterson Dental Supply Extends Partnership With PDS Health Through 2027 | SAINT PAUL (dpa-AFX) - Patterson Dental Supply, Inc., a unit of Patterson Companies, Inc. (PDCO), Wednesday announced extended partnership with PDS Health, a dental and medical support organization... ► Artikel lesen | |
| FULGENT GENETICS | 16,800 | -2,89 % | Fulgent Genetics stock hits 52-week low at $18.76 | ||
| SENSEONICS | 0,281 | +4,66 % | Senseonics Holdings, Inc.: Eversense 365 Receives FDA Clearance: The World's First One Year CGM | Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus... ► Artikel lesen |
MOTUS GI HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,429 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOTUS GI HOLDINGS INC finden Sie auf Wallstreet Online.
